TScan Therapeutics, Inc. (TCRX)

TScan Therapeutics Revenue

TScan Therapeutics had revenue of $1.05M in the quarter ending June 30, 2026, a decrease of -65.83%. This brings the company's revenue in the last twelve months to $7.11M, up 2.15% year-over-year. In the year 2025, TScan Therapeutics had annual revenue of $10.33M with 266.65% growth.

• Revenue (ttm): $7.11M
• Revenue Growth: +2.15%
• P/S Ratio: 7.09
• Revenue / Employee: $51,158
• Employees: 139
• Market Cap: 49.54M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	10.33M	7.51M	266.65%
Dec 31, 2024	2.82M	-18.23M	-86.62%
Dec 31, 2023	21.05M	7.51M	55.52%
Dec 31, 2022	13.54M	3.39M	33.47%
Dec 31, 2021	10.14M	9.06M	834.65%
Dec 31, 2020	1.09M	-	-
Dec 31, 2019	-	-	-

Data Source: Fiscal.ai Last updated: Aug 12, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 14, 2026

Data Sources Report a data error